Home/Filings/4/0001104659-24-100769
4//SEC Filing

Fairmount Healthcare Fund II L.P. 4

Accession 0001104659-24-100769

CIK 0001590750other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 9:00 PM ET

Size

9.7 KB

Accession

0001104659-24-100769

Insider Transaction Report

Form 4
Period: 2024-09-13
Transactions
  • Purchase

    Common Stock

    2024-09-13$18.75/sh+1,600,000$30,000,0003,445,813 total(indirect: Fairmount Healthcare Fund II LP)
Transactions
  • Purchase

    Common Stock

    2024-09-13$18.75/sh+1,600,000$30,000,0003,445,813 total(indirect: Fairmount Healthcare Fund II LP)
Transactions
  • Purchase

    Common Stock

    2024-09-13$18.75/sh+1,600,000$30,000,0003,445,813 total(indirect: Fairmount Healthcare Fund II LP)
Footnotes (1)
  • [F1]Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001769651

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 9:00 PM ET
Size
9.7 KB